COMP <GO>
PACS vs ENSG // EV/EBITDA & P/E VALUATION
PACS Group Inc. (NYSE) VS. The Ensign Group Inc. (NASDAQ) • 15-METRIC TALLY: PACS 6
— ENSG 7
▲ EV/EBITDA & P/E VALUATION LEADER: PACS
LAST: $47.81 (-3.76%) • MKT CAP: $7.87B
valuation
15.5x
LAST: $181.52 (-2.58%) • MKT CAP: $10.87B
valuation
17.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PACS VS. ENSG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PACS | ENSG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 20.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.60% | 18.00% | +6.60 | PACS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.5x | 17.0x | -1.50 | PACS | /valuation <GO> |
| Free Cash Flow Yield | 2.11% | 3.11% | -1.00 | ENSG | /fcf-yield <GO> |
| Operating Margin | 5.90% | 8.50% | -2.60 | ENSG | /operating-margins <GO> |
| Net Profit Margin | 3.60% | 6.80% | -3.20 | ENSG | /net-margins <GO> |
| Revenue Growth (YoY) | 29.40% | 18.80% | +10.60 | PACS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.13% | -0.13 | ENSG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.24 | 3.73 | -1.49 | ENSG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | PACS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.4 | 60.2 | +3.20 | PACS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.89 | +0.06 | PACS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.5x | 26.5x | +8.00 | ENSG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.87B | $10.87B | -$3.00B | ENSG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PACS REV | ENSG REV | PACS GROSS % | ENSG GROSS % | PACS FCF | ENSG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.29B | $5.03B | — | 20.1% | $166.3M | $337.8M |
| FY 2024 | $4.09B | $4.24B | — | 20.3% | $183.4M | $156.5M |
| FY 2023 | $3.11B | $3.71B | — | — | -$76.3M | $209.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PACS // BETA 0.95
ENSG // BETA 0.89